Universe Pharmaceuticals Inc. (UPC) Stock Analysis & Investment Frameworks

Universe Pharmaceuticals Inc. (UPC) stock analysis on Invetso. Review Universe Pharmaceuticals Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.

Universe Pharmaceuticals Inc. Company Overview

Universe Pharmaceuticals Inc. Key Financial Metrics

About Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.

Universe Pharmaceuticals Inc. Investment Frameworks

Invetso analyzes Universe Pharmaceuticals Inc. (UPC) across the following frameworks:

Explore More UPC Research